BMB 201
Alternative Names: BMB-201Latest Information Update: 04 Dec 2024
Price :
$50 *
At a glance
- Originator Bright Minds Biosciences
- Class Analgesics; Antidepressants
- Mechanism of Action 5-HT2C serotonin receptor agonists; Serotonin 5-HT2A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Depressive disorders; Pain
Most Recent Events
- 16 Oct 2024 Preclinical trials in Depressive disorders in Canada (unspecified route) prior to October 2024
- 16 Oct 2024 Preclinical trials in Pain in Canada (unspecified route) prior to October 2024
- 16 Oct 2024 Pharmacodynamics data from a preclinical study in Pain released by Bright Minds Biosciences